Articles with "hepatocellular cholangiocarcinoma" as a keyword



Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer Medicine"

DOI: 10.1002/cam4.2495

Abstract: Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) and intrahepatic cholangiocarcinoma (ICC) are classified into one category, but comparison of prognosis of the two carcinomas remains controversial. The aim of the current study was to investigate surgical outcomes for patients… read more here.

Keywords: combined hepatocellular; hepatocellular cholangiocarcinoma; intrahepatic cholangiocarcinoma; cholangiocarcinoma ... See more keywords

Prognostic significance of three‐tiered pathological classification for microvascular invasion in patients with combined hepatocellular‐cholangiocarcinoma following hepatic resection

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5328

Abstract: Previous studies have reported that the microvascular invasion three‐tiered grading (MiVI‐TTG) scheme is a better prognostic predictor than the two‐tiered microvascular invasion (MiVI) grading scheme in hepatocellular carcinoma. This study aims to explore the prognostic… read more here.

Keywords: prognostic significance; combined hepatocellular; three tiered; hepatocellular cholangiocarcinoma ... See more keywords

Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights From a Western Single‐Center Study

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27955

Abstract: Primary liver malignancies, such as hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular‐cholangiocarcinoma (cHCC‐CCA), represent significant contributors to global cancer‐related mortality. The diagnostic challenges associated with distinguishing cHCC‐CCA from HCC and ICC stem from… read more here.

Keywords: prognostic impact; combined hepatocellular; hepatocellular cholangiocarcinoma; cholangiocarcinoma ... See more keywords

Comment On “Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular‐Cholangiocarcinoma: Insights from a Western Single‐Center Study”

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.28021

Abstract: Prognostic Impact of the Cholangiolar Component in Combined Hepatocellular ‐ Cholangiocarcinoma: Insights From a Western Single ‐ Center read more here.

Keywords: prognostic impact; combined hepatocellular; component combined; impact cholangiolar ... See more keywords

Mixed Hepatocellular‐Cholangiocarcinoma: Is It Time to Rethink Consideration for Liver Transplantation?

Sign Up to like & get
recommendations!
Published in 2018 at "Liver Transplantation"

DOI: 10.1002/lt.25325

Abstract: Recognition of a mixed hepatocellular-cholangiocarcinoma (HCC-CCA) in a candidate is generally considered a contraindication to liver transplantation (LT) due to a perception of poor posttransplant survival and high recurrence rates.1 Due to the relative rarity… read more here.

Keywords: hepatocellular cholangiocarcinoma; transplantation; liver transplantation; consideration ... See more keywords

Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors

Sign Up to like & get
recommendations!
Published in 2022 at "European Radiology"

DOI: 10.1007/s00330-022-08691-w

Abstract: To investigate the role of clinicopathological factors and MR imaging factors in risk stratification of combined hepatocellular cholangiocarcinoma (cHCC-CCA) patients who were classified as LR-M and LR-4/5. We retrospectively identified consecutive patients who were confirmed… read more here.

Keywords: rfs; chcc cca; risk stratification; clinicopathological factors ... See more keywords

Tertiary lymphoid structures as a potential prognostic biomarker for combined hepatocellular–cholangiocarcinoma

Sign Up to like & get
recommendations!
Published in 2024 at "Hepatology International"

DOI: 10.1007/s12072-024-10694-2

Abstract: Combined hepatocellular–cholangiocarcinoma (cHCC–CCA), as a rare primary hepatic tumor, is challenging to accurately assess in terms of the clinical outcomes and prognostic risk factors in patients. This study aimed to clarify the function of tertiary… read more here.

Keywords: cca; combined hepatocellular; chcc cca; tls ... See more keywords

Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer letters"

DOI: 10.1016/j.canlet.2019.05.023

Abstract: Primary liver cancer ranks among the leading causes of cancer death worldwide. Risk factors are closely linked to inflammation, such as viral hepatitis and alcoholic as well as non-alcoholic steatohepatitis. Among the pathways involved in… read more here.

Keywords: tumor phenotype; combined hepatocellular; hepatocellular cholangiocarcinoma; cholangiocarcinoma ... See more keywords
Photo from archive.org

Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.

Sign Up to like & get
recommendations!
Published in 2020 at "Human pathology"

DOI: 10.1016/j.humpath.2019.11.001

Abstract: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver carcinoma showing variable degrees of differentiation toward hepatocellular and cholangiocellular carcinoma. Its great heterogeneity in term of morphology, immunophenotype, molecular, radiological and clinical features represents a challenge… read more here.

Keywords: updates diagnosis; combined hepatocellular; hepatocellular cholangiocarcinoma; chcc cca ... See more keywords
Photo from archive.org

A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.

Sign Up to like & get
recommendations!
Published in 2019 at "Seminars in liver disease"

DOI: 10.1055/s-0039-3402515

Abstract: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a primary liver tumor with neoplastic components of both hepatocytic and cholangiocytic differentiation. This unique neoplasm is gaining increasing recognition due to the intriguing pathology, tumor biology, and clinical behavior. It… read more here.

Keywords: hepatocellular cholangiocarcinoma; update combined; review update; combined hepatocellular ... See more keywords

Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem‐cell features, intermediate‐cell type

Sign Up to like & get
recommendations!
Published in 2019 at "Hepatology Research"

DOI: 10.1111/hepr.13365

Abstract: Combined hepatocellular cholangiocarcinoma, subtype with stem‐cell features, intermediate‐cell subtype (INT) shows various histological appearances and could be misdiagnosed as intrahepatic cholangiocarcinoma (iCCA). In the present study, we aimed to identify specific histological diagnostic markers of… read more here.

Keywords: cholangiocarcinoma subtype; combined hepatocellular; hepatocellular cholangiocarcinoma; cholangiocarcinoma ... See more keywords